The present invention is directed to a new class of 6-sulfonamido-quinolin-2-one and 6-sulfonamido-2-oxo-chromene derivatives to their use as androgen antagonists, and to relieve conditions associated with inappropriate activation of the androgen receptor.

 
Web www.patentalert.com

< Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use

< Highly lipophilic camptothecin intermediates and prodrugs and methods of preparation thereof

> Method for determining biological expression levels by linear programming

> Thiophene-amd thiazolesulfonamides as antineoplastic agents
~ 00272